Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07039513

EVOLUTION OF D-DIMER AS A MARKER OF BLEEDING RISK ON ECMO

Sponsor: University Hospital, Strasbourg, France

View on ClinicalTrials.gov

Summary

ECMO (extracorporeal membrane oxygenation) is a life-saving device, used in intensive care to treat severe respiratory or cardiac failure. However, it carries a high risk of serious life-threatening bleeding. Bleeding complications have been attributed to coagulopathy triggered either by the underlying pathology or by the extracorporeal circuit itself, as well as excessive or inappropriate anticoagulation initiated to prevent thrombotic complications. The objective of this cohort is to confirm the interest of the evolution of D-dimers as a prognostic marker of serious bleeding events in patients on veno-venous (VV) or veno-arterial (VA) ECMO, and to determine the threshold.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

100

Start Date

2025-11-27

Completion Date

2027-06-01

Last Updated

2025-12-01

Healthy Volunteers

No

Interventions

OTHER

Blood sampling collection

Collection of an additional of 2.7mL citrate tube of blood for a D-dimer dosage.

Locations (1)

Service de Médecine Intensive - Réanimation Nouvel Hôpital Civil

Strasbourg, France